Natera Quarterly Income Statement
NASDAQ: NTRAHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Natera revenue and earnings
In the quarter ended Jun 30, 2026, Natera generated $752.8 million in revenue, up 37.7% from the same quarter a year earlier. Natera reported a net loss of $67.0 million, compared with a loss of $100.9 million a year earlier. Operating margin was -10.1%.
Diluted earnings per share came in at -$0.47.
Summary generated from market data by MetaCap's automated system. Methodology
Natera income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 752.75M | 696.64M | 665.50M | 592.18M | 546.60M | 501.83M | 476.06M | 439.76M | 413.35M | 367.74M | 311.11M | 268.31M |
| Revenue growth (YoY) | +37.71% | +38.82% | +39.79% | +34.66% | +32.24% | +36.46% | +53.02% | +63.90% | +58.13% | +52.11% | +43.20% | +27.38% |
| Research & Development | 228.07M | 210.70M | 175.19M | 173.41M | 146.43M | 129.08M | 129.46M | 96.93M | 89.11M | 88.64M | 82.96M | 77.23M |
| Selling, General & Admin | 327.20M | 327.94M | 291.30M | 308.55M | 310.55M | 266.86M | 234.92M | 214.15M | 197.97M | 194.28M | 161.43M | 154.74M |
| Operating Income | -75.79M | -93.52M | -22.79M | -97.58M | -110.37M | -79.18M | -64.74M | -39.34M | -43.90M | -74.31M | -84.54M | -110.98M |
| Interest Expense | 890.00K | 892.00K | 991.00K | 1.04M | 1.03M | 1.00M | 1.29M | 3.14M | 3.13M | 3.12M | 3.15M | 3.25M |
| Other Income (Expense) | 9.45M | 9.60M | — | — | 10.74M | 13.42M | — | — | — | — | — | — |
| Pretax Income | -67.23M | -84.81M | -13.33M | -87.34M | -100.66M | -66.76M | -55.13M | -30.86M | -36.57M | -67.17M | -77.84M | -108.83M |
| Income Tax | -261.00K | 283.00K | -60.58M | 207.00K | 275.00K | 173.00K | -1.35M | 730.00K | 892.00K | 428.00K | 191.00K | 202.00K |
| Net Income | -66.97M | -85.09M | 47.26M | -87.54M | -100.94M | -66.94M | -53.77M | -31.59M | -37.46M | -67.60M | -78.03M | -109.03M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.47 | -0.60 | 0.36 | -0.64 | -0.74 | -0.50 | -0.41 | -0.26 | -0.30 | -0.56 | -0.63 | -0.95 |
| EPS (Diluted) | -0.47 | -0.60 | 0.36 | -0.64 | -0.74 | -0.50 | -0.41 | -0.26 | -0.30 | -0.56 | -0.63 | -0.95 |
| Shares Outstanding (Basic) | 143.28M | 141.50M | — | 137.19M | 136.39M | 134.75M | — | 123.78M | 122.85M | 120.81M | — | 115.17M |
| Shares Outstanding (Diluted) | 143.28M | 141.50M | — | 137.19M | 136.39M | 134.75M | — | 123.78M | 122.85M | 120.81M | — | 115.17M |
| EBITDA | -60.31M | -79.00M | -10.41M | -87.28M | -100.51M | -69.94M | -56.95M | -31.14M | -35.99M | -67.25M | -77.63M | -104.00M |
| Operating Margin | -10.07% | -13.42% | -3.42% | -16.48% | -20.19% | -15.78% | -13.60% | -8.95% | -10.62% | -20.21% | -27.17% | -41.36% |
| Net Margin | -8.90% | -12.21% | 7.10% | -14.78% | -18.47% | -13.34% | -11.29% | -7.18% | -9.06% | -18.38% | -25.08% | -40.64% |
This table shows 12 quarterly periods of Natera's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow NTRA's reporting calendar. What is a income statement?